The Effects of Pregnancy on the Pharmacokinetics of Infliximab and Adalimumab in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

Update on the Management of Inflammatory Bowel Disease: Specific Role of Adalimumab

Clinical and Experimental Gastroenterology
Gastroenterology
2011English

Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Insights Into the Treatment of Inflammatory Bowel Disease in Pregnancy

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

The Impact of Inflammatory Bowel Disease on Pregnancy and the Fetus: A Literature Review

Cureus
2019English

Pregnancy Outcomes of Women With Inflammatory Bowel Disease

Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor
2013English

Pgi9 - Systematic Review and Meta-Analysis of the Efficacy of Infliximab Biosimilars in Inflammatory Bowel Disease Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Gastroenterology
HepatologyGastroenterology
2016English

Does Infliximab Increase Complications After Surgery for Inflammatory Bowel Disease?

F1000 Medicine Reports
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy